Skyrizi

Active Ingredient(s): Risankizumab-rzaa
FDA Approved: * April 23, 2019
Pharm Company: * ABBVIE INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Skyrizi Overview

Risankizumab also known by the substance codes as BI-655066 and ABBV-066 or the trade name Skyrizi is a humanized monoclonal antibody targeting interleukin 23A (IL-23A).[1] Risankizumab is part of a collaboration between Boehringer Ingelheim and AbbVie. Risankizumab has been approved in Europe, USA and Japan for treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. Clinical Drug Trial Information Psoriasis In a phase I clinica...

Read more Skyrizi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Risankizumab

Recent Skyrizi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Risankizumab-rzaa
  • Injection: 75mg/0.83ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Skyrizi: (1 result)

Sorted by National Drug Code
  • 0074-2042 SkyriziSkyrizi Kit by Abbvie Inc.

Other drugs which contain Risankizumab-rzaa or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 May 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA